These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3535528)

  • 1. Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection.
    Demetris AJ; Jaffe R; Sheahan DG; Burnham J; Spero J; Iwatsuki S; Van Theil DH; Starzl TE
    Am J Pathol; 1986 Oct; 125(1):161-72. PubMed ID: 3535528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations.
    Demetris AJ; Todo S; Van Thiel DH; Fung JJ; Iwaki Y; Sysyn G; Ming W; Trager J; Starzl TE
    Am J Pathol; 1990 Sep; 137(3):667-76. PubMed ID: 2399936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should liver transplantation be performed for patients with hepatitis B?
    Eason JD; Freeman RB; Rohrer RJ; Lewis WD; Jenkins R; Dienstag J; Cosimi AB
    Transplantation; 1994 Jun; 57(11):1588-93. PubMed ID: 8009592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation.
    Flowers M; Sherker A; Sinclair SB; Greig PD; Cameron R; Phillips MJ; Blendis L; Chung SW; Levy GA
    Transplantation; 1994 Jul; 58(2):183-92. PubMed ID: 8042236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
    Seehofer D; Rayes N; Steinmüller T; Müller AR; Settmacher U; Neuhaus R; Radke C; Berg T; Hopf U; Neuhaus P
    Liver Transpl; 2001 Nov; 7(11):976-82. PubMed ID: 11699034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fulminant hepatitis B virus: recurrence after liver transplantation in two patients also infected with hepatitis delta virus.
    Marsman WA; Wiesner RH; Batts KP; Poterucha JJ; Porayko MK; Niesters HG; Zondervan PE; Krom RA
    Hepatology; 1997 Feb; 25(2):434-8. PubMed ID: 9021960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of hepatitis B relapse after liver transplantation.
    Zhu X; Lu M; Wang G; Cai C; Yang Y; He X; Chen G; Huang J
    Chin Med J (Engl); 2001 Jan; 114(1):73-5. PubMed ID: 11779441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liver transplantation in patients with cirrhosis secondary to hepatitis B virus and hepatitis C virus infections].
    Lucena JF; Herrero JI
    An Sist Sanit Navar; 2004; 27 Suppl 2():91-101. PubMed ID: 15381947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [De novo hepatitis B infection after liver transplantation--evidence for the need of active hepatitis B vaccination of liver transplantation candidates].
    Rambusch EG; Nashan B; Tillmann HL; Böker KH; Schlitt HJ; Maschek H; Raab R; Manns MP
    Z Gastroenterol; 1998 Dec; 36(12):1027-35. PubMed ID: 10025054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts.
    Doria C; di Francesco F; Marino IR; Ramirez CB; Frank A; Iaria M; Galati SA; Farber JL
    Transplant Proc; 2006 Dec; 38(10):3597-600. PubMed ID: 17175342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
    Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants.
    Aardema KL; Nakhleh RE; Terry LK; Burd EM; Ma CK; Moonka DK; Brown KA; Abouljoud MS
    Mod Pathol; 1999 Nov; 12(11):1043-9. PubMed ID: 10574601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of hepatitis B virus cirrhosis and hepatocellular carcinoma: an indication for retransplantation?
    Ringe B; Böker K; Schlitt HJ; Sproviero J; Hundrieser J; Tillmann HL; Chavan A; Flemming P; Galanski M; Pichlmayr R
    Clin Transplant; 1995 Jun; 9(3 Pt 1):190-6. PubMed ID: 7549059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
    Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis B virus reactivation in patients with HBs antibodies after allogeneic hematopoietic stem cell transplantation].
    Fujimaki K; Nakaseko C; Oshima K; Sakai M; Chou R; Kanda Y; Nishimura M; Kanamori H; Sakamaki H
    Rinsho Ketsueki; 2007 May; 48(5):386-90. PubMed ID: 17571583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen.
    Demetris AJ; Lasky S; Van Thiel DH; Starzl TE; Dekker A
    Am J Pathol; 1985 Jan; 118(1):151-61. PubMed ID: 3881037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late hepatic allograft dysfunction.
    Wiesner RH; Menon KV
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S60-73. PubMed ID: 11689778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation.
    Angus PW; Locarnini SA; McCaughan GW; Jones RM; McMillan JS; Bowden DS
    Hepatology; 1995 Jan; 21(1):14-8. PubMed ID: 7806147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.